Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and Toxicity

NCT00886535 · clinicaltrials.gov ↗

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer
Ductal Carcinoma in Situ

Sponsor

Milton S. Hershey Medical Center